RESEARCH PEPTIDE
CJC-1295 5 mg
CJC-1295 5 mg
CJC-1295 is studied within growth hormone-releasing hormone research for its influence on GH and IGF-1 signalling.
Quality documentation
Certificate of Analysis Available
View the available testing documentation for CJC-1295 5 mg.
IDR 1.399.000
- Product
- CJC-1295
- Strength
- 5 mg
- Category
- Research Peptides
- Purity
- ≥99.6% PURITY
- Use
- Laboratory and scientific research only
- Price
- IDR 1.399.000
Growth hormone-releasing hormone analogue research.
CJC-1295 is studied within growth hormone-releasing hormone research for its influence on GH and IGF-1 signalling.
Research context
Published CJC-1295 studies examine GHRH-analogue signalling and downstream GH and IGF-1 responses. Interpretation depends on the exact molecular formulation.
Research interests
- GHRH-analogue signalling
- Growth-hormone response
- IGF-1 pathway research
Explore further
Related research products
Research Peptides≥99.6% PURITY10 mg
AOD-9604 is a modified C-terminal growth-hormone fragment studied in preclinical lipid-metabolism, fat-oxidation, and adipose-signalling models.
≥99.6% PURITY
IDR 3.499.000
Research Peptides≥99.6% PURITY10 mg
BPC-157 is studied in preclinical models of tendon-fibroblast migration, FAK–paxillin activation, and tissue-repair signalling.
≥99.6% PURITY
IDR 1.199.000
Research Peptides≥99.6% PURITY10 mg
DSIP is an exploratory neuropeptide studied at the intersection of slow-wave EEG activity, sleep signalling, and neuroendocrine regulation.
≥99.6% PURITY
IDR 2.199.000
Research Peptides≥99.6% PURITY100 mg
GHK-Cu is a copper-binding tripeptide studied across collagen synthesis, extracellular-matrix accumulation, and tissue-remodelling signalling.
≥99.6% PURITY
IDR 1.799.000